Lino Ferreira did postdoctoral work at INEB (Portugal) and MIT (USA) in the areas of Regenerative Medicine. He established his research group in 2008 at the University of Coimbra. Since then is the director of the Advanced Therapies research group, CNC coordinator of the MIT-Portugal Program and the founder of the biotech companies Matera and Curemat. Since 2019, he is the associate editor of Biomaterials Science Journal (RSC) journal. In 2012, he was awarded with a prestigious European Research Council starting grant and in 2016 a prestigious ERA Chair position in the area of Ageing at the University of Coimbra. Since 2020, he is the coordinator of the Colab4Ageing, a collaborative laboratory that integrates companies, health and social providers, in the area of ageing. His group has interest in the development of ageing models and in the creation of new therapeutic approaches to fight ageing, in particular cardiovascular ageing.

At the 2023 Longevity Med Summit Lino Ferreira will introduce the lecture about “Ageing: modelling and potential interventions”.